2026-10-30 01:25:59 UTC#542143newconfirmednews
Insilico Medicine stock news
Insilico Medicine stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-09-30 05:57:00 UTC#389148newconfirmedpress release
Insilico Medicine nominates ISM1354 as next-generation GIPR antagonist for weight management
2026-09-17 15:21:00 UTC#328476newconfirmedpress release
Insilico Medicine Releases Open-Source LongevityBench and Longevity-LLMs for Aging Biology Research
2026-09-14 01:51:11 UTC#304788newconfirmednews
Insilico Medicine Cayman TopCo Chairman Purchased 113,500 Shares Between Sept 4-7
2026-09-10 00:30:00 UTC#288769newconfirmedpress release
Insilico Medicine initiates world's first Phase III trial for AI-discovered drug Rentosertib
2026-09-08 13:15:18 UTC#280950duplicateconfirmednews
Insilico Medicine's AI-designed drug rentosertib shows potential to reverse biological aging markers in small trial
2026-09-08 03:29:00 UTC#278127duplicateconfirmednews
Insilico shares rise 8.2% as Citi analysts validate rentosertib antiaging study findings
dow_jonesimportance 0.30trust 0.80Insilico Medicine +0.50rentosertib +0.50Citigroup Inc. +0.30+1 entities
2026-09-07 11:30:08 UTC#275989duplicateconfirmednews
Insilico's AI-developed lung drug shows potential to reverse biological aging markers
2026-09-07 09:42:00 UTC#275531duplicateconfirmednews
Insilico's AI-designed rentosertib shows biological age reversal potential in Nature Biotechnology study
2026-09-07 09:08:00 UTC#275389duplicatereportednews
Insilico Co-CEO Zhavoronkov highlights potential for fibrosis drug to reverse biological aging
2026-09-07 09:01:00 UTC#275341newconfirmednews
Insilico CEO Zhavoronkov discusses potential of fibrosis drug rentosertib to impact biological aging
dow_jonesimportance 0.30trust 0.70Insilico Medicine +0.20Alex Zhavoronkov 0rentosertib +0.30+1 entities
2026-09-07 09:00:00 UTC#275350updateconfirmednews
Insilico's AI-designed rentosertib shows anti-aging potential in Nature Biotechnology Phase 2a study
dow_jonesimportance 0.50trust 0.80Insilico Medicine +0.50rentosertib +0.50Nature Biotechnology 0+2 entities
2026-09-04 00:26:49 UTC#265733newconfirmednews
Insilico Medicine Chairman Aleksandrs Zavoronkovs to purchase up to HKD 16 million in shares in September 2026
2026-09-03 00:30:00 UTC#259383newconfirmedpress release
Insilico Medicine (3696) to join HKEX Tech 100 Index
pr newswireimportance 0.40trust 0.90Insilico Medicine +0.50Hong Kong Exchanges and Clearing Limited +0.30HKEX Tech 100 Index +0.30+1 entities
2026-09-02 23:59:00 UTC#259305duplicateconfirmedanalysis
Citi initiates coverage of Insilico Medicine with Buy rating, HK$85 price target
2026-09-02 23:59:00 UTC#259304updateconfirmednews
Citigroup sets HK$85 price target on InSilico Medicine following coverage initiation
2026-09-02 23:59:00 UTC#259303newconfirmednews
Citigroup initiates coverage of InSilico Medicine at Buy with High Risk rating
2026-08-28 01:38:40 UTC#232709newconfirmednews
Insilico Medicine Cayman Enters Agreement for $305 Million Bond Issuance
2026-08-26 10:50:00 UTC#222383updateconfirmednews
Insilico Medicine (3696.HK) 1H Revenue Growth Driven by Drug Discovery Pipeline and Upfront Payments
2026-08-26 10:49:00 UTC#222392updateconfirmeddata release